The only statistically significant finding was the observation that GH(+)/PRL(+) tumors presented a higher PRL concentration and higher rate of gonadotropin deficiency, which complies with the common endocrine knowledge [4]. This evidence concerns the gene GH1 and Gonadotropin deficiency.